Literature DB >> 15177772

Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis.

Marcin P Mycko1, Ruben Papoian, Ursula Boschert, Cedric S Raine, Krzysztof W Selmaj.   

Abstract

Multiple sclerosis, a primary autoimmune disease of the central nervous system has been characterized by the presence of the demyelinating lesions (plaques) in the CNS. To further understand the gene transcription status of the two most common lesions, chronic active and chronic inactive, we have performed a cDNA microarray analysis of these two lesion type. Comparative analysis of differential gene expression of chronic active and inactive lesions have confirmed the existence of a significant difference in the transcriptional profiles of these two lesion types in both marginal and central areas. Different sets of genes were highlighted, including genes of inflammatory characteristics, apoptosis related and stress-induced, indicating their potential role in MS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15177772     DOI: 10.1016/j.clineuro.2004.02.019

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  25 in total

Review 1.  Gene expression profiling in neurological disorders: toward a systems-level understanding of the brain.

Authors:  Sergio E Baranzini
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 2.  Epigenetic principles and mechanisms underlying nervous system functions in health and disease.

Authors:  Mark F Mehler
Journal:  Prog Neurobiol       Date:  2008-10-17       Impact factor: 11.685

3.  The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage.

Authors:  Wensheng Lin; Samantha L Bailey; Hanson Ho; Heather P Harding; David Ron; Stephen D Miller; Brian Popko
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

Review 4.  Single-Cell RNA Sequencing: Unraveling the Brain One Cell at a Time.

Authors:  Dimitry Ofengeim; Nikolaos Giagtzoglou; Dann Huh; Chengyu Zou; Junying Yuan
Journal:  Trends Mol Med       Date:  2017-05-10       Impact factor: 11.951

5.  Endoplasmic reticulum stress response as a potential therapeutic target in multiple sclerosis.

Authors:  Meghann Teague Getts; Daniel R Getts; Adam P Kohm; Stephen D Miller
Journal:  Therapy       Date:  2008-09-01

6.  Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gamma.

Authors:  Wensheng Lin; Phillip E Kunkler; Heather P Harding; David Ron; Richard P Kraig; Brian Popko
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

Review 7.  Endoplasmic reticulum stress in disorders of myelinating cells.

Authors:  Wensheng Lin; Brian Popko
Journal:  Nat Neurosci       Date:  2009-03-15       Impact factor: 24.884

Review 8.  Multiple sclerosis and regulatory T cells.

Authors:  Cristina Maria Costantino; Clare Baecher-Allan; David A Hafler
Journal:  J Clin Immunol       Date:  2008-09-02       Impact factor: 8.317

9.  Convergent functional genomics of oligodendrocyte differentiation identifies multiple autoinhibitory signaling circuits.

Authors:  Rosanna Pescini Gobert; Lara Joubert; Marie-Laure Curchod; Catherine Salvat; Isabelle Foucault; Catherine Jorand-Lebrun; Marc Lamarine; Hélène Peixoto; Chloé Vignaud; Christèle Frémaux; Thérèse Jomotte; Bernard Françon; Chantal Alliod; Lilia Bernasconi; Hadi Abderrahim; Dominique Perrin; Agnes Bombrun; Francisca Zanoguera; Christian Rommel; Rob Hooft van Huijsduijnen
Journal:  Mol Cell Biol       Date:  2009-01-12       Impact factor: 4.272

10.  Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures.

Authors:  Robert P Lisak; Joyce A Benjamins; Beverly Bealmear; Liljana Nedelkoska; Diane Studzinski; Ernest Retland; Bin Yao; Susan Land
Journal:  J Neuroinflammation       Date:  2009-01-21       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.